James W Green
CIK 1400121 · View on SEC EDGAR ↗
First SEC filing: April 30, 2015 · Latest: April 30, 2015
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 13, 2024 | HBIO | P | 10,000 | $2.91 | $29,100 | 3,111,091 Direct | +0.32% | Acquired | -73.9% (price as of 2026-08-21) |
| June 6, 2024 | HBIO | P | 20,000 | $3.07 | $61,400 | 3,101,091 Direct | +0.65% | Acquired | -75.3% (price as of 2026-08-21) |
| Aug. 17, 2023 | HBIO | P | 25,000 | $4.38 | $109,500 | 2,862,679 Direct | +0.88% | Acquired | -82.7% (price as of 2026-08-21) |
| March 15, 2023 | HBIO | P | 20,000 | $2.60 | $52,000 | 2,886,052 Direct | +0.70% | Acquired | -70.8% (price as of 2026-08-21) |
| March 14, 2023 | HBIO | P | 20,000 | $2.67 | $53,400 | 2,866,052 Direct | +0.70% | Acquired | -71.6% (price as of 2026-08-21) |
| Dec. 1, 2022 | HBIO | P | 15,000 | $2.61 | $39,150 | 2,278,811 Direct | +0.66% | Acquired | -70.9% (price as of 2026-08-21) |
| Nov. 30, 2022 | HBIO | P | 15,000 | $2.41 | $36,150 | 2,263,811 Direct | +0.67% | Acquired | -68.5% (price as of 2026-08-21) |
| Aug. 17, 2022 | HBIO | P | 40,000 | $3.19 | $127,600 | 2,248,811 Direct | +1.81% | Acquired | -76.2% (price as of 2026-08-21) |
| June 15, 2022 | HBIO | P | 30,000 | $3.71 | $111,300 | 2,301,582 Direct | +1.32% | Acquired | -79.5% (price as of 2026-08-21) |
| May 9, 2022 | HBIO | P | 10,000 | $3.40 | $34,000 | 2,319,955 Direct | +0.43% | Acquired | -77.7% (price as of 2026-08-21) |
| May 6, 2022 | HBIO | P | 30,000 | $3.78 | $113,400 | 2,309,955 Direct | +1.32% | Acquired | -79.9% (price as of 2026-08-21) |
| Aug. 23, 2021 | HBIO | S | 48,175 | $8.02 | $386,364 | 2,091,725 Direct | -2.25% | Disposed | -90.5% (price as of 2026-08-21) |
| May 21, 2021 | HBIO | S | 24,312 | $7.14 | $173,588 | 2,279,778 Direct | -1.06% | Disposed | -89.4% (price as of 2026-08-21) |
| May 20, 2021 | HBIO | S | 14,876 | $7.03 | $104,578 | 2,279,778 Direct | -0.65% | Disposed | -89.2% (price as of 2026-08-21) |
| May 19, 2021 | HBIO | S | 39,188 | $7.17 | $280,978 | 2,279,778 Direct | -1.69% | Disposed | -89.4% (price as of 2026-08-21) |
| May 18, 2021 | HBIO | S | 39,188 | $7.41 | $290,383 | 2,279,788 Direct | -1.69% | Disposed | -89.8% (price as of 2026-08-21) |
| March 12, 2021 | HBIO | S | 35,000 | $5.98 | $209,300 | 2,279,778 Direct | -1.51% | Disposed | -87.3% (price as of 2026-08-21) |
| May 7, 2020 | HBIO | P | 10,000 | $2.53 | $25,300 | 1,512,445 Direct | +0.67% | Acquired | -70.0% (price as of 2026-08-21) |
| Nov. 11, 2019 | HBIO | P | 10,000 | $2.61 | $26,100 | 1,535,404 Indirect | +0.66% | Acquired | -70.9% (price as of 2026-08-21) |
| Aug. 16, 2019 | HBIO | P | 10,000 | $2.48 | $24,800 | 1,525,404 Indirect | +0.66% | Acquired | -69.4% (price as of 2026-08-21) |
| Aug. 9, 2019 | HBIO | P | 20,000 | $2.47 | $49,400 | 1,515,404 Indirect | +1.34% | Acquired | -69.3% (price as of 2026-08-21) |
| Aug. 29, 2018 | HBIO | P | 2,500 | $5.74 | $14,350 | 159,812 Direct | +1.59% | Acquired | -86.8% (price as of 2026-08-21) |
| Aug. 29, 2018 | HBIO | P | 2,500 | $5.74 | $14,350 | 154,187 Direct | +1.65% | Acquired | -86.8% (price as of 2026-08-21) |
| Aug. 28, 2018 | OSIS | P | 250 | $76.65 | $19,162 | 4,064 Direct | +6.55% | Acquired | 154.4% (price as of 2026-08-21) |
| June 8, 2017 | HBIO | P | 7,712 | $2.55 | $19,666 | 110,212 Direct | +7.52% | Acquired | -70.2% (price as of 2026-08-21) |
Showing latest 100 of 101 transactions
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| May 21, 2021 | HBIO | Stock option (right to buy) | Common Stock (24,312) | $2.63 | June 11, 2027 | 24,312 | Disposed |
| May 20, 2021 | HBIO | Stock option (right to buy) | Common Stock (14,876) | $2.63 | June 11, 2027 | 14,876 | Disposed |
| May 19, 2021 | HBIO | Stock option (right to buy) | Common Stock (39,188) | $2.63 | June 11, 2027 | 39,188 | Disposed |
| May 18, 2021 | HBIO | Stock option (right to buy) | Common Stock (39,188) | $2.63 | June 11, 2027 | 39,188 | Disposed |
| June 11, 2020 | HBIO | Stock option (right to buy) | Common Stock (470,254) | $2.63 | June 11, 2027 | 470,254 | Acquired |
| May 5, 2015 | HBIO | Non-Qualified Stock Option (right to buy) | Common Stock, par value $0.01 per share (60,000) | $5.27 | May 5, 2025 | 60,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| April 30, 2015 | HBIO | Common Stock | 2,000 | Indirect |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $336,923 | — | — | — | — | — | $18,900 | $355,823 |
| 2024 | $513,431 | — | $1,800,000 | — | — | — | $23,145 | $2,336,576 |
| 2023 | $585,625 | — | $1,772,760 | — | — | — | $33,855 | $2,392,240 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.